Bioprocess Containers Market Size & Growth Forecast 2027–2036, By Segments (Product, Application, End Use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Jump to Content
Market Size and Growth Outlook
Bioprocess Containers Market size was around USD 5.01 billion in 2026 and is slated to grow at a 23.05% CAGR from 2027 to 2036, exceeding USD 39.87 billion by 2036. The industry revenue for 2027 is calculated at USD 6.03 billion.
Get more details on this report
Request Free Sample ReportBioprocess Containers Market Intelligence Snapshot
Regional Market Dynamics
- Asia Pacific accounted for 38.88% of market revenue, supported by expanding biopharmaceutical manufacturing, growing biologics demand, and adoption of single-use containers that improve production flexibility and reduce contamination risks.
- North America is anticipated to grow fastest as biomanufacturing investments, biologics production, and cell and gene therapy development increase demand for flexible single-use systems and reliable fluid management solutions.
Segment Momentum
- 2D bioprocess containers hold 49.82% market share in 2026, driven by their space-efficient design, reduced contamination exposure, and suitability for single-use manufacturing workflows that simplify handling and reduce cleaning requirements.
- Pharmaceutical and biopharmaceutical companies account for 61.8% of market share in 2026 and are expected to grow fastest, as biologics, vaccines, and cell-based therapies increase demand for scalable, contamination-conscious fluid handling solutions.
Market Expansion Drivers
- Rising Adoption of Single-use Bioprocess Containers.
- Growth in Biopharmaceutical Manufacturing.
- Innovations in Container Design & Sterility.
Leading Market Participants
- Leading players in the bioprocess containers market include Thermo Fisher Scientific (USA), Sartorius (Germany), Merck KGaA (Germany), Cytiva (USA), Lonza (Switzerland), Saint-Gobain (France), Corning (USA), Entegris (USA), Meissner Filtration Products (USA), AdvantaPure (USA).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 5.01 billion
- 2027 Estimated Market Size: USD 6.03 billion
- Projected Market Size: USD 39.87 billion by 2036
- Growth Forecast: 23.05% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: Asia Pacific
- High-Growth Regional Hub: North America
- Core Revenue Segment: Product (2D Bioprocess Containers) | Application (Upstream Processes) | End Use (Pharmaceutical & Biopharmaceutical Companies)
- Emerging Opportunity Segment: Product (2D Bioprocess Containers) | Application (Upstream Processes) | End Use (Pharmaceutical & Biopharmaceutical Companies)
Market Growth Drivers and Industry Trends
Rising Adoption of Single-use Bioprocess Containers
The rising adoption of single-use bioprocess containers is supporting market growth as biopharmaceutical manufacturers increasingly seek flexible solutions that can simplify processing operations and reduce the complexity associated with reusable equipment. Single-use systems can help minimize cleaning and sterilization requirements while reducing the risk of cross-contamination between production cycles. Their flexibility and suitability for modular manufacturing are also encouraging adoption across development, clinical, and commercial bioprocessing environments.
Growth in Biopharmaceutical Manufacturing
The growth in biopharmaceutical manufacturing is driving demand for bioprocess containers as expanding production of biologics requires efficient and contamination-controlled solutions for fluid handling, storage, and processing. Increasing development of complex biological products and the growing use of advanced manufacturing workflows are creating greater requirements for flexible process equipment. Bioprocess containers are increasingly being incorporated into manufacturing operations to support efficient material handling while helping facilities adapt to changing production requirements.
Innovations in Container Design & Sterility
Innovations in container design and sterility are contributing to market expansion by improving the reliability, flexibility, and safety of solutions used in biopharmaceutical processing. Advances in materials, sealing technologies, connector systems, and manufacturing processes are helping improve container integrity while supporting compatibility with increasingly sophisticated production workflows. Enhanced sterility assurance and design flexibility are also encouraging broader adoption where maintaining product quality and minimizing contamination risks are critical.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising Adoption of Single-use Bioprocess Containers | 8% | Short term (≤ 2 yrs) | North America; Europe | Medium | Fast |
| Growth in Biopharmaceutical Manufacturing | 7.5% | Medium term (2–5 yrs) | Asia Pacific; North America | Medium | Moderate |
| Innovations in Container Design & Sterility | 7% | Long term (5+ yrs) | Europe; Asia Pacific | Low | Moderate |
Explore Growth Opportunities
Request Free Sample ReportRegional Demand Dynamics
Asia Pacific (Largest Region)
Asia Pacific dominated the global bioprocess containers market, accounting for the largest revenue share of 38.88%. The region’s expanding biopharmaceutical manufacturing capabilities, growing demand for biologics, and increasing investments in bioprocessing infrastructure are key factors supporting market growth. Bioprocess containers are gaining importance in pharmaceutical manufacturing because they offer flexible, single-use solutions for the storage, handling, and transfer of biological fluids. Furthermore, the growing adoption of single-use technologies is helping manufacturers streamline production workflows, reduce cleaning requirements, and minimize contamination risks. The expansion of biologics development and contract manufacturing activities is further strengthening demand for bioprocess containers across the region.
North America (Fastest-Growing Region)
The North America bioprocess containers market is anticipated to register the fastest growth, driven by the expansion of biopharmaceutical production, increasing adoption of single-use manufacturing technologies, and rising demand for advanced biologics. Pharmaceutical and biotechnology manufacturers are increasingly adopting flexible production systems that support efficient manufacturing operations and reduce the complexities associated with traditional reusable equipment. In addition, the growing development of cell and gene therapies and other complex biologics is increasing the need for reliable fluid management and contamination-control solutions. Continued investment in biomanufacturing infrastructure and the growing emphasis on production efficiency are further contributing to market expansion across North America.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation HubiScaleNascentDeveloping Advanced | |||||
| Cost-Sensitive RegioniScaleLowMedium High | |||||
| Regulatory EnvironmentiScaleRestrictiveNeutral Supportive | |||||
| Demand DriversiScaleWeakModerate Strong | |||||
| Development StageiScaleEmergingDeveloping Developed | |||||
| Adoption RateiScaleLowMedium High | |||||
| New Entrants / StartupsiScaleSparseModerate Dense | |||||
| Macro IndicatorsiScaleWeakStable Strong |
Key Country Insights
United States 🇺🇸
Flexible Bioprocess AdoptionThe U.S. continues to prioritize single-use bioprocessing across biologics manufacturing, with demand centered on scalable, contamination-controlled container systems. Suppliers are likely to focus on customized assemblies, higher-volume manufacturing, and compatibility with increasingly automated cell and gene therapy workflows.
Germany 🇩🇪
Advanced Manufacturing IntegrationGermany’s bioprocessing base supports demand for reliable single-use containers integrated into sophisticated production environments. Market priorities include validated materials, process consistency, automation compatibility, and supply reliability as pharmaceutical manufacturers expand flexible manufacturing capabilities.
Japan 🇯🇵
Quality-Driven Single UseJapan’s pharmaceutical manufacturing environment places strong emphasis on quality, process reliability, and regulatory consistency in bioprocess containers. Suppliers can prioritize high-purity materials, robust quality controls, and application-specific container assemblies suited to biologics and advanced therapeutic production.
South Korea 🇰🇷
Biologics Capacity ExpansionSouth Korea’s expanding biologics manufacturing ecosystem is supporting greater use of single-use technologies throughout upstream and downstream processes. Container suppliers can target large-scale production facilities with scalable systems, customized assemblies, and dependable supply chains for biologics manufacturing.
France 🇫🇷
Biopharma Process FlexibilityFrance’s biopharmaceutical manufacturing activity creates opportunities for flexible single-use container systems that reduce cleaning requirements and support multiproduct facilities. Commercial priorities include validated components, efficient fluid handling, and solutions adaptable to biologics and advanced therapy manufacturing processes.
Italy 🇮🇹
Specialized Bioprocess SolutionsItaly’s pharmaceutical manufacturing landscape supports demand for specialized single-use containers across development and production applications. Suppliers can emphasize customized bags and assemblies, material compatibility, and efficient small- to medium-scale processing where flexible manufacturing configurations provide operational advantages.
Bioprocess Containers Market Share (%), by Product, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportProduct Segment Analysis: 2D Bioprocess Containers (Largest & Fastest-Growing Segment)
The 2D bioprocess containers segment accounted for the largest 2026 market share of 49.82% and is also expected to register the fastest growth during the forecast period. Its strong market position is supported by the broad use of flexible two-dimensional containers for handling, storing, and transporting biopharmaceutical materials throughout different stages of bioprocessing. These containers provide advantages such as space efficiency, reduced contamination exposure, and suitability for single-use processing environments, making them increasingly relevant to modern pharmaceutical manufacturing workflows. Their flexible construction can also simplify storage and handling while reducing the cleaning and sterilization requirements associated with traditional reusable equipment. As biopharmaceutical manufacturers increasingly adopt single-use technologies to improve process flexibility, reduce operational complexity, and accelerate manufacturing workflows, 2026 demand for 2D bioprocess containers is expanding. The growing emphasis on contamination control and efficient material handling across bioprocessing operations is expected to further support adoption and reinforce the segment's position as a key growth area.
Application Segment Analysis: Upstream Processes (Largest & Fastest-Growing Segment)
The upstream processes segment accounted for the largest market share of 58.71% in 2026 and is also expected to experience the fastest growth during the forecast period. Its dominance is closely linked to the increasing use of single-use technologies in activities such as cell culture, media preparation, buffer handling, and other processes involved in the early stages of biopharmaceutical production. Bioprocess containers can provide flexible and controlled solutions for managing materials during upstream operations while reducing the need for extensive cleaning and sterilization infrastructure. This is particularly valuable as manufacturers seek to improve production flexibility, shorten processing timelines, and reduce contamination risks. The expansion of biologics and advanced therapies is further increasing the complexity and scale of upstream manufacturing activities, creating greater demand for efficient fluid management solutions. As biopharmaceutical production continues to shift toward flexible and scalable processing approaches, the use of bioprocess containers in upstream processes is expected to expand substantially in 2026.
End Use Segment Analysis: Pharmaceutical & Biopharmaceutical Companies (Largest & Fastest-Growing Segment)
,The pharmaceutical & biopharmaceutical companies segment accounted for the largest market share of 61.8% in 2026 and is also expected to grow at the fastest pace during the forecast period. Its leading position reflects the extensive use of bioprocess containers across pharmaceutical and biopharmaceutical manufacturing activities, where controlled fluid handling, contamination prevention, and process efficiency are critical requirements. These companies are increasingly adopting single-use bioprocessing technologies to support flexible production, reduce equipment-related downtime, and simplify manufacturing operations. The growing development and commercialization of biologics, vaccines, cell-based therapies, and other complex pharmaceutical products is creating additional demand for specialized containment and fluid management solutions. In addition, manufacturers are increasingly seeking scalable processing technologies that can accommodate changing production requirements while maintaining consistent quality and operational control. The continued expansion of biopharmaceutical manufacturing capacity and increasing adoption of single-use processing systems are therefore expected to support sustained demand for bioprocess containers within this end-use segment in 2026.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product | 2D Bioprocess Containers, 3D Bioprocess Containers, Others | 2D Bioprocess Containers | 2D Bioprocess Containers |
| Application | Upstream Processes, Downstream Processes, Process Developments | Upstream Processes | Upstream Processes |
| End Use | Pharmaceutical & Biopharmaceutical Companies, Contract Research Organizations & Contract Manufacturing Organizations, Academic & Research Institutes, Others | Pharmaceutical & Biopharmaceutical Companies | Pharmaceutical & Biopharmaceutical Companies |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Competitive Landscape and Market Positioning
Analyst Perspective:
Quality assurance, material integrity, and operational agility define competitive positioning in the bioprocess containers sector. Biopharmaceutical manufacturers evaluate suppliers through extensive extractables and leachables (E&L) risk profiling, requiring rigorous documentation to ensure container materials do not compromise product safety or regulatory qualification. Differentiation depends on multi-layer film technology that combines mechanical flexibility with broad chemical compatibility. Furthermore, as single-use architectures expand into automated fluid-handling workflows, suppliers win market share by offering scalable custom configurations and automated assembly options—all while maintaining robust supply chain security and strict change-control practices to protect continuous drug manufacturing schedules.
Key companies in the bioprocess containers market:
- Thermo Fisher Scientific (USA)
- Sartorius (Germany)
- Merck KGaA (Germany)
- Cytiva (USA)
- Lonza (Switzerland)
- Saint-Gobain (France)
- Corning (USA)
- Entegris (USA)
- Meissner Filtration Products (USA)
- AdvantaPure (USA)
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Thermo Fisher Scientific (USA) | |||||||
| Sartorius (Germany) | |||||||
| Merck KGaA (Germany) | |||||||
| Cytiva (USA) | |||||||
| Lonza (Switzerland) | |||||||
| Saint-Gobain (France) | |||||||
| Corning (USA) | |||||||
| Entegris (USA) | |||||||
| Meissner Filtration Products (USA) | |||||||
| AdvantaPure (USA) |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Single Use Support | June 2026 | Single Use Support launched the RoSS.BLST blast freezer, a 21 CFR Part 11-compliant platform designed for scalable biologics freeze-thaw processes. The system provides 30% greater chamber capacity within the same footprint and accommodates up to 192 × 2L bottles per batch for temperature protocols down to -80 °C. |
| Thermo Fisher Scientific | May 2026 | Thermo Fisher Scientific introduced the Gibco CTS DynaXS Single-Use Bioreactor as part of an integrated platform aimed at scalable cell therapy manufacturing. The launch extends single-use capability for sensitive, closed processing workflows where contamination control and rapid changeover support clinical and commercial supply strategies. |
| Lonza | October 2025 | Lonza received Swissmedic approval and achieved operational readiness for a new aseptic drug product filling line in Stein, Switzerland. The regulatory clearance supports fill-finish capacity for biologics manufacturing programs that rely on validated sterile handling and compatible single-use fluid management components. |
| Lonza | November 2024 | Lonza completed the first good manufacturing practice batch at its next-generation mammalian manufacturing facility in Portsmouth, United States, using single-use systems. Bringing a new single-use-enabled site to operational execution expands the installed base for disposable process-contact containers across upstream and downstream workflows. |
| ILC Dover | May 2022 | ILC Dover launched its liquid single-use bioprocessing bags constructed from medical-grade Renolit 9101 film for sterile liquid handling in biotherapeutic markets. The configurable bags meet BPOG, ISO, and USP standards, expanding the company's line of single-use solutions aimed at improving manufacturing efficiency and sterility. |
| Avantor, Inc. | June 2021 | Avantor, Inc. acquired RIM Bio, a China-based manufacturer of single-use bioprocess bags and assemblies for biopharmaceutical applications. This acquisition expanded the company's bioproduction manufacturing footprint and commercial capabilities within the region. |
| Merck KGaA | March 2021 | Merck KGaA invested approximately USD 30 million to add a single-use assembly production unit at its Life Science Center in Molsheim, France. This facility expansion accelerated the company's European single-use technology deployment for manufacturing vaccines and therapies. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Bioprocess Containers Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Bioprocess Scale | Laboratory & Research Scale, Clinical Scale, Commercial Manufacturing Scale |
| Volume Capacity | Up to 50 Liters, 51–500 Liters, 501–2,000 Liters, Above 2,000 Liters |
| System Configuration | Container-only Systems, Container Assemblies, Integrated Single-use Systems |
Bioprocess Containers Market — Custom TOC
| Custom Chapter | Chapter Details |
|---|---|
| Single-Use Adoption Roadmap |
|
| Biopharma Procurement & Qualification Dynamics |
|
| Container Integrity & Risk Management |
|
Need a different cut of the data?
Request Custom ResearchFrequently Asked Questions
What is the total addressable market for bioprocess containers?
What is the expected industry size of bioprocess containers by 2036?
How is the shift toward single-use processing influencing bioprocess container adoption?
How are biopharmaceutical manufacturing requirements driving innovation in bioprocess container design?
Why do 2D bioprocess containers dominate the bioprocess containers market?
How are pharmaceutical and biopharmaceutical companies driving bioprocess container demand?
What makes Asia Pacific the leading market for bioprocess containers?
Why is North America expected to grow fastest in the bioprocess containers market?
Which organizations are considered leaders in the bioprocess containers landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.
Delivery
Published
Available
Support
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook